Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The AAA+ ATPase subunits (Rpt1-Rpt6 or PSMC1-PSMC6) of the 19S regulatory particle are essential components of the eukaryotic ubiquitin-proteasome system (UPS). They form a heterohexameric ring that uses ATP hydrolysis to unfold target proteins and translocate them into the 20S core particle for degradation. The C-terminal tails of these ATPases are critical for opening the gate of the 20S particle. Dysregulation or mutation can contribute to diseases like cancer, making them potential therapeutic targets.
ATP hydrolysis-dependent protein unfolding and translocation into the 20S proteasome core particle for degradation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 19S Regulatory Particle AAA+ ATPases (19S RP ATPases).